AU646342B2 - New substituted 16-methyl steroid derivatives of pregna-1,4-diene-3,20-dione, their preparation, their use in the preparation of 16-methylene steroids and new intermediates - Google Patents
New substituted 16-methyl steroid derivatives of pregna-1,4-diene-3,20-dione, their preparation, their use in the preparation of 16-methylene steroids and new intermediates Download PDFInfo
- Publication number
- AU646342B2 AU646342B2 AU18478/92A AU1847892A AU646342B2 AU 646342 B2 AU646342 B2 AU 646342B2 AU 18478/92 A AU18478/92 A AU 18478/92A AU 1847892 A AU1847892 A AU 1847892A AU 646342 B2 AU646342 B2 AU 646342B2
- Authority
- AU
- Australia
- Prior art keywords
- formula
- compound
- action
- compounds
- order
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9107784A FR2678275B1 (fr) | 1991-06-25 | 1991-06-25 | Nouveaux sterouides 16-methyl substitue derives de la pregna 1,4-diene 3,20-dione leur preparation, leur application a la preparation de sterouides 16-methylene et nouveaux intermediaires. |
| FR9107784 | 1991-06-25 | ||
| CN92105005A CN1035948C (zh) | 1991-06-25 | 1992-06-25 | 孕甾-1，4-二烯-3，20-二酮衍生物的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1847892A AU1847892A (en) | 1993-01-07 |
| AU646342B2 true AU646342B2 (en) | 1994-02-17 |
Family
ID=36781528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18478/92A Ceased AU646342B2 (en) | 1991-06-25 | 1992-06-24 | New substituted 16-methyl steroid derivatives of pregna-1,4-diene-3,20-dione, their preparation, their use in the preparation of 16-methylene steroids and new intermediates |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5248773A (enExample) |
| EP (1) | EP0520879B1 (enExample) |
| JP (1) | JP3037508B2 (enExample) |
| KR (1) | KR100220540B1 (enExample) |
| CN (1) | CN1035948C (enExample) |
| AT (1) | ATE152119T1 (enExample) |
| AU (1) | AU646342B2 (enExample) |
| CA (1) | CA2072053C (enExample) |
| DE (1) | DE69219217T2 (enExample) |
| DK (1) | DK0520879T3 (enExample) |
| ES (1) | ES2100315T3 (enExample) |
| FR (1) | FR2678275B1 (enExample) |
| GR (1) | GR3023294T3 (enExample) |
| HU (1) | HU213674B (enExample) |
| MX (1) | MX9202972A (enExample) |
| RU (1) | RU2099346C1 (enExample) |
| ZA (1) | ZA924665B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU226413B1 (en) * | 1991-06-25 | 2008-11-28 | Aventis Pharma Sa | Novel 16-(nitro-substituted methyl)pregna-1,4-dien-3,20-dion derivatives and process for producing them |
| FR2692266B1 (fr) * | 1992-06-11 | 1994-08-05 | Roussel Uclaf | Nouveau procede de preparation de sterouides 16 alpha-methyles. |
| CN1061984C (zh) * | 1996-04-18 | 2001-02-14 | 上海华联制药有限公司 | 甾体激素化合物中引入9-11双键的一种方法 |
| HUE027463T2 (en) | 2008-05-28 | 2016-09-28 | Reveragen Biopharma Inc | Non-hormonal steroid modulators of nf-kb for treatment of disease |
| US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0179496A1 (en) * | 1982-09-20 | 1986-04-30 | The Upjohn Company | 16-Sulfinylmethyl-steroids, their preparation and use |
| EP0148616B1 (en) * | 1984-01-05 | 1991-04-17 | The Upjohn Company | Stabilised monolithium acetylide and the ethynylation of steroids |
-
1991
- 1991-06-25 FR FR9107784A patent/FR2678275B1/fr not_active Expired - Fee Related
-
1992
- 1992-06-18 MX MX9202972A patent/MX9202972A/es unknown
- 1992-06-23 CA CA002072053A patent/CA2072053C/fr not_active Expired - Lifetime
- 1992-06-24 HU HU9202100A patent/HU213674B/hu unknown
- 1992-06-24 JP JP4188932A patent/JP3037508B2/ja not_active Expired - Lifetime
- 1992-06-24 ES ES92401764T patent/ES2100315T3/es not_active Expired - Lifetime
- 1992-06-24 DE DE69219217T patent/DE69219217T2/de not_active Expired - Lifetime
- 1992-06-24 AU AU18478/92A patent/AU646342B2/en not_active Ceased
- 1992-06-24 AT AT92401764T patent/ATE152119T1/de active
- 1992-06-24 RU SU925011969A patent/RU2099346C1/ru active
- 1992-06-24 KR KR1019920010983A patent/KR100220540B1/ko not_active Expired - Lifetime
- 1992-06-24 EP EP92401764A patent/EP0520879B1/fr not_active Expired - Lifetime
- 1992-06-24 ZA ZA924665A patent/ZA924665B/xx unknown
- 1992-06-24 DK DK92401764.3T patent/DK0520879T3/da active
- 1992-06-25 CN CN92105005A patent/CN1035948C/zh not_active Expired - Fee Related
- 1992-06-25 US US07/903,886 patent/US5248773A/en not_active Expired - Lifetime
-
1997
- 1997-04-30 GR GR960402901T patent/GR3023294T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT61569A (en) | 1993-01-28 |
| KR930000534A (ko) | 1993-01-15 |
| CN1068120A (zh) | 1993-01-20 |
| FR2678275B1 (fr) | 1995-06-23 |
| GR3023294T3 (en) | 1997-07-30 |
| MX9202972A (es) | 1993-04-01 |
| JP3037508B2 (ja) | 2000-04-24 |
| EP0520879A2 (fr) | 1992-12-30 |
| HU9202100D0 (en) | 1992-10-28 |
| CA2072053C (fr) | 2003-10-21 |
| ATE152119T1 (de) | 1997-05-15 |
| EP0520879A3 (enExample) | 1995-04-12 |
| AU1847892A (en) | 1993-01-07 |
| CN1035948C (zh) | 1997-09-24 |
| CA2072053A1 (fr) | 1992-12-26 |
| KR100220540B1 (ko) | 1999-10-01 |
| RU2099346C1 (ru) | 1997-12-20 |
| DE69219217T2 (de) | 1997-11-13 |
| FR2678275A1 (fr) | 1992-12-31 |
| DE69219217D1 (de) | 1997-05-28 |
| HU213674B (en) | 1997-09-29 |
| ES2100315T3 (es) | 1997-06-16 |
| JPH05186496A (ja) | 1993-07-27 |
| DK0520879T3 (da) | 1997-10-20 |
| ZA924665B (en) | 1993-06-24 |
| US5248773A (en) | 1993-09-28 |
| EP0520879B1 (fr) | 1997-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI80888C (fi) | Foerfarande foer framstaellning av terapeutiskt verkande steroida karboxylsyraestrar. | |
| JPH01500907A (ja) | ９―α―ヒドロキシステロイド及びその製法 | |
| HU227380B1 (en) | Process for preparing delta 9,11 and 21-chloro corticosteroids | |
| DK165838B (da) | Analogifremgangsmaade til fremstilling af 17,17-bis(substitueret thio)-3-ketoandrostenforbindelser | |
| JPH0559097A (ja) | １７−（ホルムアミド−スルホニルメチレン）−ステロイド及びその製造方法 | |
| US4310467A (en) | Process and intermediates for the synthesis of vitamin D3 metabolites | |
| AU725606B2 (en) | Process for the preparation of 17-esters of 9alpha,21- dihalo-pregnane-11beta,17alpha-diol-20-ones | |
| HU182615B (en) | Process for producing 16-unsaturated pregnanes | |
| EP0189951A1 (en) | New process for the preparation of certain steroids, especially intermediates for the preparation of proligestone and related compounds, and new intermediates formed in this process | |
| AU2003259022A1 (en) | Process to prepare eplerenone | |
| KR100220540B1 (ko) | 프레그나-1,4-디엔-3,20-디온의 치환 16-메틸 스테로이드 유도체, 그의 제조방법, 16-메틸렌 스테로이드 제조에서의 그의 용도 및 중간체 | |
| US4464302A (en) | 17-[(Hydroxymethyl)formamido-methylene]-steroids | |
| US5616743A (en) | 16-methyl-Δ1,4 -pregnadiene-3,20-diones | |
| AU689564B2 (en) | New preparation process for a 16B-methyl steroid and new intermediates | |
| EP1242444A1 (en) | Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates | |
| IE922042A1 (en) | New substituted 16-methyl steroid derivatives of¹pregna-1,4-diene-3,20-dione, their preparation, their use in¹the preparation of 16-methylene steroids and new¹intermediates | |
| US4990612A (en) | 16α-methylation process | |
| US3832366A (en) | Process for preparing 21-chloro-17-acyloxy-20-ketosteroids | |
| CA1255296A (en) | [16,17-a]cyclopentano pregnenes | |
| US20040127702A1 (en) | Novel crystal form | |
| HU215270B (hu) | Eljárás 20-oxo-17alfa,21-dihidroxi-szteroidok előállítására | |
| US4031080A (en) | 16-Alpha-methyl-17 alpha-bromo-1,4-pregnadiene-21-ol-3,20-dione-derivatives | |
| HU203768B (en) | New metilating process for producing 16-alpha-methyl-steroides | |
| US4323512A (en) | Process for the preparation of steroidal 17α-arylcarboxylates | |
| WO2003010181A1 (es) | PROCEDIMIENTO ESTEREOSELECTIVO PARA LA PRODUCCIÓN DE 6α-FLUORPREGNANOS E INTERMEDIOS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired | ||
| PC | Assignment registered |
Owner name: AVENTIS PHARMA S.A. Free format text: FORMER OWNER WAS: HOECHST MARION ROUSSEL |